Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2018 1
2019 8
2020 13
2021 8
2022 5
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Angiogenic imbalances: the obstetric perspective.
Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM. Espinoza J, et al. Among authors: espinoza af. Am J Obstet Gynecol. 2010 Jul;203(1):17.e1-8. doi: 10.1016/j.ajog.2009.10.891. Epub 2010 Mar 15. Am J Obstet Gynecol. 2010. PMID: 20231008 Review.
Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma.
Whitlock RS, Portuondo JI, Espinoza AF, Ortega R, Galván NTN, Leung DH, Lopez-Terrada D, Masand P, Nguyen HN, Patel KA, Goss JA, Heczey AM, Vasudevan SA. Whitlock RS, et al. Among authors: espinoza af. J Pediatr Surg. 2023 Sep;58(9):1715-1726. doi: 10.1016/j.jpedsurg.2023.05.001. Epub 2023 May 8. J Pediatr Surg. 2023. PMID: 37244849
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.
Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. Ludmir EB, et al. Among authors: espinoza af. J Natl Cancer Inst. 2019 Dec 1;111(12):1358-1360. doi: 10.1093/jnci/djz117. J Natl Cancer Inst. 2019. PMID: 31165160 Free PMC article. Review.
Characterization of Suboptimal Responses to Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia.
Espinoza J, King A, Shamshirsaz AA, Nassr AA, Donepudi R, Sanz Cortes M, Meholin-Ray AR, Krispin E, Johnson R, Mendez Martinez Y, Keswani SG, Lee TC, Joyeux L, Espinoza AF, Olutoye Ii O, Garcia-Prats JA, Fernandes CJ, Coleman RD, Lohmann P, Rhee CJ, Davies J, Belfort MA. Espinoza J, et al. Among authors: espinoza af. Fetal Diagn Ther. 2023;50(2):128-135. doi: 10.1159/000530549. Epub 2023 Apr 11. Fetal Diagn Ther. 2023. PMID: 37040717
Sex-Based Disparities Among Cancer Clinical Trial Participants.
Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E. Ludmir EB, et al. Among authors: espinoza af. J Natl Cancer Inst. 2020 Feb 1;112(2):211-213. doi: 10.1093/jnci/djz154. J Natl Cancer Inst. 2020. PMID: 31350545 Free PMC article.
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: espinoza af. Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20. Eur J Cancer. 2020. PMID: 32702645 Free PMC article. Review.
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials.
Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: espinoza af. Mayo Clin Proc. 2021 Feb;96(2):420-426. doi: 10.1016/j.mayocp.2020.08.015. Mayo Clin Proc. 2021. PMID: 33549260 Review.
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma.
Espinoza AF, Patel RH, Patel KR, Badachhape AA, Whitlock R, Srivastava RK, Govindu SR, Duong A, Kona A, Kureti P, Armbruster B, Kats D, Srinivasan RR, Dobrolecki LE, Yu X, Najaf Panah MJ, Zorman B, Sarabia SF, Urbicain M, Major A, Bissig KD, Keller C, Lewis MT, Heczey A, Sumazin P, López-Terrada DH, Woodfield SE, Vasudevan SA. Espinoza AF, et al. J Hepatol. 2024 Apr;80(4):610-621. doi: 10.1016/j.jhep.2024.01.003. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242326
41 results